、投資有価証券評価損益(△は益)、無形資産(IFRS)他2件
- 【期間】
年度 | | 投資有価証券評価損益(△は益) | 無形資産(IFRS) | その他 | 研究開発費 |
---|
2008/03 | - | | 34.7億 | | - | | 188億 | | - | |
2009/03 | - | | 29.1億 | -16% | - | | 141億 | -25% | - | |
2010/03 | - | | 0.33億 | -98.9% | - | | 187億 | +32.6% | - | |
2011/03 | - | | - | | - | | 133億 | -28.9% | - | |
2011/12 | - | | - | | - | | 126億 | -5.4% | - | |
2012/12 | - | | - | | - | | 139億 | +10.5% | 126億 | |
2013/12 | - | | - | | - | | 180億 | +29.2% | 123億 | -2.2% |
2014/12 | - | | - | | - | | 196億 | +9.2% | - | |
2015/12 | - | | - | | - | | 156億 | -20.7% | - | |
2016/12 | - | | - | | - | | 149億 | -4.2% | - | |
2017/12 | 3878億 | | - | | - | | 97.5億 | -34.7% | - | |
2018/12 | 3822億 | -1.4% | - | | 466億 | | 19.6億 | -79.9% | - | |
2019/12 | 4277億 | +11.9% | - | | 421億 | -9.5% | 23.4億 | +19.1% | - | |
2020/12 | - | | - | | 365億 | -13.4% | 17億 | -27.2% | - | |
2021/12 | - | | - | | 361億 | -1.1% | 21.8億 | +28.1% | - | |
2022/12 | - | | - | | 372億 | +3% | 72.1億 | +231.2% | - | |
2023/12 | - | | - | | 730億 | +96.4% | 85.8億 | +19% | - | |